RO 611790

Drug Profile

RO 611790

Alternative Names: VML 588

Latest Information Update: 15 Aug 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Anti-ischaemics; Dioxanes; Neuroprotectants; Pyridines; Pyrimidines; Small molecules; Sulfonamides; Tetrazoles
  • Mechanism of Action Endothelin A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Renal failure; Subarachnoid haemorrhage

Most Recent Events

  • 15 Aug 2000 Discontinued-I for Renal failure in World (IV)
  • 15 Aug 2000 Discontinued-I for Subarachnoid haemorrhage in World (IV)
  • 24 May 2000 Vanguard Medica is now called Vernalis Group
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top